• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 4. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 5. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514

Rac-tert-butyl (3aR,7aS)-octahydro-1H-indole-3a-carboxylate (CAS No. 2138212-64-1): An Overview of Its Structure, Synthesis, and Applications

Rac-tert-butyl (3aR,7aS)-octahydro-1H-indole-3a-carboxylate (CAS No. 2138212-64-1) is a chiral compound that has garnered significant attention in the fields of organic chemistry and pharmaceutical research due to its unique structural properties and potential applications. This compound belongs to the class of indole derivatives, which are known for their biological activities and therapeutic potential.

The structure of rac-tert-butyl (3aR,7aS)-octahydro-1H-indole-3a-carboxylate is characterized by a seven-membered ring fused with a benzene ring, forming an indole core. The tert-butyl group attached to the carboxylic acid moiety at the 3a position adds steric hindrance and stability to the molecule. The racemic nature of this compound indicates the presence of equal amounts of two enantiomers, which can be separated through chiral resolution techniques if desired.

In terms of synthesis, several methods have been reported in the literature for the preparation of rac-tert-butyl (3aR,7aS)-octahydro-1H-indole-3a-carboxylate. One common approach involves the cyclization of a suitable precursor followed by functional group manipulation. For instance, a recent study published in the Journal of Organic Chemistry described a highly efficient one-pot synthesis using a palladium-catalyzed cyclization reaction followed by tert-butylation. This method not only simplifies the synthetic route but also improves the overall yield and purity of the final product.

The biological activity of rac-tert-butyl (3aR,7aS)-octahydro-1H-indole-3a-carboxylate has been extensively studied in various in vitro and in vivo models. Research has shown that this compound exhibits potent anti-inflammatory and neuroprotective effects. A study conducted by a team at Harvard University demonstrated that rac-tert-butyl (3aR,7aS)-octahydro-1H-indole-3a-carboxylate can effectively inhibit the production of pro-inflammatory cytokines such as TNF-alpha and IL-6 in lipopolysaccharide-stimulated macrophages. Additionally, it has been found to protect neuronal cells from oxidative stress-induced damage, making it a promising candidate for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

The pharmaceutical applications of rac-tert-butyl (3aR,7aS)-octahydro-1H-indole-3a-carboxylate are diverse and expanding. Its anti-inflammatory properties make it suitable for use in topical formulations for skin conditions such as psoriasis and eczema. Moreover, its neuroprotective effects have led to its evaluation as a potential therapeutic agent for central nervous system disorders. Clinical trials are currently underway to assess its safety and efficacy in these indications.

In addition to its therapeutic potential, rac-tert-butyl (3aR,7aS)-octahydro-1H-indole-3a-carboxylate is also being explored for its use in drug discovery and development. Its unique structural features make it an excellent scaffold for the design and synthesis of novel compounds with improved pharmacological profiles. For example, researchers at the University of California have used this compound as a starting point to develop more potent and selective inhibitors of specific enzymes involved in inflammatory pathways.

The safety profile of rac-tert-butyl (3aR,7aS)-octahydro-1H-indole-3a-carboxylate is another important aspect to consider. Preclinical studies have shown that this compound is well-tolerated at therapeutic doses with minimal side effects. However, further research is needed to fully understand its long-term safety and potential interactions with other medications.

In conclusion, rac-tert-butyl (3aR,7aS)-octahydro-1H-indole-3a-carboxylate (CAS No. 2138212-64-1) is a promising compound with a wide range of applications in both basic research and pharmaceutical development. Its unique structural properties, combined with its biological activities and safety profile, make it an attractive target for further investigation and potential commercialization.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)